Genomictree Inc. (KOSDAQ:228760)
South Korea · Delayed Price · Currency is KRW 22,450
-900 (-3.85%)
At close: Feb 6, 2026
Genomictree Market Cap
Genomictree has a market cap or net worth of 544.78 billion as of February 6, 2026. Its market cap has increased by 6.12% in one year.
Market Cap
544.78B
Enterprise Value
461.95B
Revenue
3.76B
Ranking
n/a
PE Ratio
n/a
Stock Price
22,450.00
Market Cap Chart
Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 544.78B, an increase of 823.38%. That is a compound annual growth rate of 28.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 544.78B | -17.38% |
| Dec 30, 2025 | 659.41B | 34.41% |
| Dec 30, 2024 | 490.60B | 0.78% |
| Dec 28, 2023 | 486.82B | 168.25% |
| Dec 29, 2022 | 181.48B | -32.87% |
| Dec 30, 2021 | 270.36B | -7.66% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medy-Tox | 887.30B |
| GI Innovation | 839.93B |
| Pharmicell | 803.45B |
| Proteina | 790.92B |
| Onconic Therapeutics | 743.34B |
| Green Cross Holdings | 677.39B |
| SillaJen | 516.61B |
| BINEX | 454.78B |